AstraZeneca sets $80 billion revenue target by 2030
Company aims to launch 20 new medicines by 2030, and reduce carbon emissions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AstraZeneca CEO
Britain presses on with AstraZeneca vaccine amid questions over trial data
Britain gave AstraZeneca’s COVID-19 vaccine a vote of confidence on Friday when it asked its regulator to assess the shot for a…
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine
AstraZeneca shot developed with Oxford University is cheaper to make, easier to distribute and faster to scale up than its rivals